Clinicopathological risk factors for lymph node metastasis and the number of CD8+ TILs, CD103+ TILs, and CD8+ CD103+ TILs were compared using sensitivity, specificity, PPV, and NPV. This evidence concerns the gene CD8A and metastatic malignant neoplasm in the lymph nodes.